Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels

GRFS
Grifois, S.A.
stock NASDAQ ADR

At Close
Jul 30, 2025 3:59:55 PM EDT
10.85USD+3.333%(+0.35)1,186,937
10.84Bid   10.86Ask   0.02Spread
Pre-market
Jul 30, 2025 9:28:30 AM EDT
10.77USD+2.571%(+0.27)29,882
After-hours
Jul 30, 2025 4:00:30 PM EDT
10.85USD0.000%(0.00)2,981
OverviewOption ChainMax PainOptionsPrice & VolumeSplitsDividendsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 4, 2022
12:30PM EST  Grifols acquires its first plasma donation center in Canada   PR Newswire
Dec 22, 2021
07:42AM EST  The Daily Biotech Pulse: Allakos Slips Negative Late-Stage Data, Pfizer & Merck Announce Fresh COVID Pill Deal With UK, Regulatory Setback For Takeda   Benzinga
Nov 30, 2021
09:02AM EST  Grifols reaches milestone with 300th U.S. plasma donor center, continuing to   PR Newswire
Nov 5, 2021
10:07AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For November 5, 2021   Benzinga
09:44AM EDT  Deutsche Bank Downgrades Grifols to Hold   Benzinga
Nov 4, 2021
09:03AM EDT  Grifols introduces ALBUTEIN FlexBag(tm) (Albumin [Human] U.S.P.) in 5% and 25%   PR Newswire
Oct 19, 2021
11:18AM EDT  Grifols and Egypt inaugurate first African plasma-supply platform, in Cairo, as   PR Newswire
Sep 17, 2021
11:30AM EDT  Grifols Earlier Announces Purchase Agreement With Tiancheng International Investment Limited; Grifols Will Acquire The Existing Share Capital Of Tiancheng Pharmaceutical Holding AG   Benzinga
03:59AM EDT  Grifols Agrees To Acquire Tiancheng (Germany) Pharmaceutical Holdings For EUR 1.1 Bln   RTTNews
Sep 16, 2021
07:48AM EDT  The Daily Biotech Pulse: Leap, Phio, Silverback Among Early Movers On Oncology Conference Presentations, Aerie Slumps On Mixed Data, Axsome Commences Phase 3 Sleep Disorder Study   Benzinga
Aug 13, 2021
07:43AM EDT  The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO   Benzinga
Aug 12, 2021
08:09AM EDT  The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma   Benzinga
Aug 11, 2021
10:36AM EDT  GigaGen Doses First Patient in Phase 1 Trial Of Recombinant Hyperimmune Polyclonal Antibody GIGA-2050 For COVID-19   Benzinga
10:26AM EDT  GigaGen Doses First Patient in Phase 1 Trial of Recombinant   GlobeNewswire Inc
08:14AM EDT  The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering   Benzinga
Jul 29, 2021
04:23AM EDT  Earnings Scheduled For July 29, 2021   Benzinga
Jul 28, 2021
08:00AM EDT  Alkahest, Inc., a clinical-stage biotechnology company focused on discovering and developing transformative therapies to treat age-related diseases and a subsidiary of Grifols, today announced the appointment of Dr. Csar Cerezo M.D., Ph.D., as chief medical officer. He will be responsible for leading and providing strategic direction to the clinical development and medical teams.   GlobeNewswire Inc
Jul 14, 2021
10:08AM EDT  Grifols Subsidiary GigaGen Highlights Publication Of Research 'Describing Novel Mechanism Of Action' And 'Therapeutic Potential' Of Its Anti-CTLA-4 Drug Candidate GIGA-564   Benzinga
10:00AM EDT  --Reduced checkpoint inhibitor activity of GIGA-564 versus current anti-CTLA-4 inhibitors results in superior anti-tumor activity and lower toxicity in murine models ---Data supports advancement of GIGA-564 into the clinic for cancer indications--   GlobeNewswire Inc
Jul 7, 2021
03:23PM EDT  Watching Grifols Shares Following Sam.gov Contract Opportunity Listing For Co.'s '2021 Vaccines For Adults (VFA)' Via CDC   Benzinga
Jun 30, 2021
05:24AM EDT  Grifols Announced Strategic Investment from GIC of $1B   Benzinga
Jun 1, 2021
10:38AM EDT  Grifols Introduces HyperHEP B (hepatitis B immune globulin [human])   Benzinga
10:31AM EDT  Grifols introduces HyperHEP B(r) (hepatitis B immune globulin [human]), a new   PR Newswire
May 25, 2021
10:15AM EDT  GigaGen Publishes Research Describing Potential New Avenues to   GlobeNewswire Inc
May 19, 2021
05:36AM EDT  Grifols Partners With Ace To Open First AMBAR Center In Barcelona   RTTNews
05:30AM EDT  Grifols takes another step in the fight against Alzheimer's, partners with Ace   PR Newswire
May 4, 2021
09:03AM EDT  Grifols Earlier Reported Q1 Sales EUR1.19B Down From EUR1.29B YoY   Benzinga
Apr 28, 2021
07:19AM EDT  Grifols, Andorran Govt. To Form Immunology Research Hub To Develop Therapeutics   RTTNews
06:45AM EDT  Grifols and Andorran government will establish world-class immunology research   PR Newswire
06:25AM EDT  Grifols Signs Agreement With Andorra Government to Create a Research Development and Innovation Centre; Centre Expected to Be Completed in 2023   Benzinga
Apr 15, 2021
12:00PM EDT  GigaGen Publishes Research on Companys   GlobeNewswire Inc
09:04AM EDT  Grifols Extends Commitment to World Federation of Hemophilia Humanitarian Aid   PR Newswire
Apr 9, 2021
10:30AM EDT  Grifols 2020 Annual Report on Form 20-F filed with the SEC on April 9, 2021   PR Newswire
Apr 2, 2021
11:19AM EDT  evaluating hyperimmune globulins as a treatment for hospitalized patients with COVID-19   PR Newswire
Mar 23, 2021
10:04AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For March 23, 2021   Benzinga
10:00AM EDT  GigaGen to Present Poster at the 2021 American Association for   GlobeNewswire Inc
06:25AM EDT  Credit Suisse Upgrades Grifols to Outperform   Benzinga
Mar 22, 2021
09:12AM EDT  Grifols Highlights Installation Of First-Ever DG Reader Net Analyzer In North America   Benzinga
09:01AM EDT  Grifols installs first-ever DG Reader Net analyzer in North America   PR Newswire
Mar 12, 2021
01:13PM EST  Grifols shares were trading higher after the company announced the board has implemented a buyback program of up to 6.875 million shares.   Benzinga
05:19AM EST  Grifols Board Implements Share Buyback Program of Up to 6.875M Shares   Benzinga
Mar 11, 2021
10:02AM EST  Benzinga's Top Ratings Upgrades, Downgrades For March 11, 2021   Benzinga
06:52AM EST  HSBC Upgrades Grifols to Buy   Benzinga
Mar 9, 2021
03:16AM EST  Grifols reinforces its innovation strategy after completing the acquisition of   PR Newswire
Mar 8, 2021
01:06PM EST  Grifols Subsidiary Alkahest Says To Present Data From Completed Phase 2 Clinical Trial At 15th International Conference On Alzheimer's And Parkingson's Disease   Benzinga
01:00PM EST  Alkahest to Present Positive Data from Completed Phase 2 Clinical   GlobeNewswire Inc
07:01AM EST  Grifols fosters world's first scientific journal specialized in blood plasma   PR Newswire
Mar 3, 2021
05:20AM EST  COVID-19 Convalescent Plasma Study Shows No Benefit, US NIH Stops Trial   Benzinga
Mar 1, 2021
05:10AM EST  Grifols Announced it Closed Transaction to Acquire 25 Plasma Donation Centers the U.S. from BPL Plasma, Inc for $370M   Benzinga
Feb 23, 2021
09:01AM EST  Grifols PharmacyKeeper ranked No. 1 as 'Best in KLAS' for fifth consecutive year   PR Newswire
Jan 28, 2021
08:02AM EST  Alkahest Announces Peer-Reviewed Publication Demonstrating Safety, Tolerability Of GRF6019 In Patients With Mild-To-Moderate Alzhimer's Disease   Benzinga
08:00AM EST  Alkahest Announces Peer-Reviewed Publication Demonstrating Safety   GlobeNewswire Inc
Jan 18, 2021
06:16AM EST  Grifols To Begin Clinical Trial To Evaluate Plasma-derived   RTTNews
06:06AM EST  Grifols To Begin A Clinical Trial Of New Treatment That Would Provide Immediate Immunity Against COVID-19 In Spain   RTTNews
06:01AM EST  Grifols begins clinical trial of a new treatment that would provide immediate   PR Newswire
Nov 16, 2020
09:15AM EST  The Dow Jones Sustainability Index recognizes Grifols as one of the world's   PR Newswire
Nov 12, 2020
09:02AM EST  Grifols partners with TRC Healthcare to streamline intravenous compounding   PR Newswire
Oct 9, 2020
08:36AM EDT  Benzinga Pro's Top 5 Stocks To Watch For Friday, Oct. 9, 2020: JPM, JNPR, VLDR, GNMK, GRFS   Benzinga
06:26AM EDT  Grifols Reports Its Anti-SARS-CoV-2 Hyperimmune Globulin, A Potential COVID-19 Treatment, Has Started Randomized Controlled Trial To Test Safety, Efficacy, Tolerability   Benzinga
06:26AM EDT  Grifols Says Anti-SARS-CoV-2 Hyperimmune Globulin Begins Clinical Trial To Test Safety   RTTNews
06:24AM EDT  Grifols' anti-SARS-CoV-2 hyperimmune globulin begins clinical trial in patients   PR Newswire
Oct 1, 2020
12:14PM EDT  Grifols closes the acquisition of Green Cross fractionation plant in Canada and   PR Newswire
Sep 8, 2020
02:33PM EDT  Mid-Afternoon Market Update: Dow Falls 1.5%; Nikola Shares Surge   Benzinga
12:00PM EDT  Mid-Day Market Update: Nasdaq Tumbles Over 300 Points; Co-Diagnostics Shares Spike Higher   Benzinga
10:46AM EDT  P/E Ratio Insights for Grifols   Benzinga
10:22AM EDT  Mid-Morning Market Update: Markets Open Lower; Grifols To Buy Geriatric Pharma Startup Alkahest   Benzinga
06:02AM EDT  A Peek Into The Markets: US Stock Futures Mostly Lower Following Last Week's Plunge   Benzinga
02:17AM EDT  Plasma-Centric Drugmaker Grifols To Buy Geriatric Pharma Startup Alkahest   Benzinga
Sep 7, 2020
03:04AM EDT  Grifols (GRFS) has agreed to acquire the remaining equity of Alkahest, Inc. in exchange for a total price of $146 million, on a debt-free basis. The closing of the deal is anticipated in early 2021.   RTTNews
02:53AM EDT  Grifols To Acquire Remaining Stock Of Alkahest For $146 Mln On A Debt-free Basis   RTTNews
02:51AM EDT  identify innovative therapies for age-related diseases based upon an understanding of the human plasma proteome   PR Newswire
Aug 24, 2020
08:32AM EDT  From Benzinga's PreMarket Prep: Co-Host Dennis Dick Says If He Was In Plasma Stocks Right Now He Would Sell Them; Notes 'This Is A Gift I Would Ring The Register Right Now'   Benzinga
Aug 10, 2020
04:06PM EDT  ICU Medical Enters Into Long-Term Agreement With Grifols To Distribute A Full Line Of Non-PVC/Non-DEHP IV Containers For 0.9% Sodium Chloride Injection, USP To Customers In The United States   Benzinga
04:00PM EDT  Long-Term U.S. Distribution Agreement with Grifols for Certain Core IV Solution Products   PR Newswire
Jul 28, 2020
10:45AM EDT  Grifols Says Delivers First Manufactured Batches Of Its Anti-SARS-CoV-2 Hyperimmune Globulin For Clinical Trials   RTTNews
10:43AM EDT  Grifols Shares Spike Higher Following Reissue Of PR Highlighting Delivery Of Manufactured Batches Of Coronavirus Hyperimmune Globulin For Clinical Trials   Benzinga
10:41AM EDT  Grifols delivers first manufactured batches of its anti-SARS-CoV-2 hyperimmune   PR Newswire
09:44AM EDT  Grifols Says Delivers First Manufactured Batches of Anti-Sars-Cov-2 Hyperimmune Globulin For Clinical Trial   Benzinga
Jul 27, 2020
01:19PM EDT  Results of Grifols' AMBAR clinical trial published in Alzheimer's & Dementia:   PR Newswire
01:03PM EDT  Grifols Shares Spike Higher After Results Of Grifols' AMBAR Clinical Trial Published In Alzheimer's & Dementia Publication   Benzinga
Jul 23, 2020
08:02AM EDT  Grifols Reports Purchase Of 10% Stake Of Bloodbuy, No Terms Disclosed   Benzinga
08:01AM EDT  Grifols acquires 10% stake in Bloodbuy, cloud-based marketplace for blood   PR Newswire
Jul 20, 2020
03:03AM EDT  Grifols (GRFS) said that it has executed purchase agreements with the South Korean-based GC Pharma (Group) whereby Grifols will acquire the Montreal-based plasma fractionation facility and two purification facilities, along with 11 U.S.-based plasma collection centers for US$460 million.   RTTNews
02:46AM EDT  Grifols Executes Purchase Arrangements With South Korean-based GC Pharma   RTTNews
02:40AM EDT  Grifols to acquire Green Cross plasma fractionation facility in Montreal and a   PR Newswire


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC